← Back to Search

Correlating Ic/Pbs Symptoms With Urine Biomarkers

N/A
Waitlist Available
Led By Michael Chancellor, MD
Research Sponsored by William Beaumont Hospitals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

Completion of a brief survey tool and providing an urine specimen. The study purpose is to improve our understanding of interstitial cystitis and painful pelvic syndrome.

Eligible Conditions
  • Chronic Prostatitis/Chronic Pelvic Pain Syndrome
  • Pelvic Pain
  • Painful Bladder Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
patients will be asked to provide a urine specimen and complete a questionnaire.

Find a Location

Who is running the clinical trial?

William Beaumont HospitalsLead Sponsor
152 Previous Clinical Trials
112,734 Total Patients Enrolled
Michael Chancellor, MDPrincipal InvestigatorWilliam Beaumont Hospitals
2 Previous Clinical Trials
45 Total Patients Enrolled
~2 spots leftby Dec 2025